| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |